These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14661866)

  • 1. Pharmacokinetics of tolbutamide after oral administration to rabbits with folate-induced renal failure.
    Choi JS; Shin SC
    Arch Pharm Res; 2003 Nov; 26(11):979-83. PubMed ID: 14661866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tolbutamide after oral administration in rabbits with folate-induced renal failure.
    Bae HY; Choi DH; Choi JS
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):237-44. PubMed ID: 15244039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits.
    Choi JS; Lee JH; Burm JP
    Arch Pharm Res; 2001 Aug; 24(4):333-7. PubMed ID: 11534767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tolbutamide following intravenous and oral administrations in rats with obstructive jaundice.
    Yamao T; Nakagami H; Furuhama K; Onodera T; Kurosaki Y; Nakayama T; Kimura T
    Biol Pharm Bull; 1994 May; 17(5):691-5. PubMed ID: 7920435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tolbutamide in acute renal failure induced by glycerol: speculative thoughts and perspectives.
    Srinivas NR
    Drug Metab Pharmacokinet; 2011; 26(2):216-7. PubMed ID: 21532212
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats.
    Choi MR; Kwon MH; Cho YY; Choi HD; Kim YC; Kang HE
    Biopharm Drug Dispos; 2014 Jul; 35(5):264-74. PubMed ID: 24590592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies on drug disposition in rabbits. III. Effect of tolbutamide on renal excretion of sulfamethizole.
    Katayama K; Ohtani H; Mizuno H; Taniguchi T; Kakemi M; Koizumi T
    J Pharmacobiodyn; 1990 Feb; 13(2):120-9. PubMed ID: 2384848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adults.
    Mazzu AL; Lettieri JT; Kelly E; Vargas R; Marbury T; Liu MC; Sundaresan P
    Eur J Clin Pharmacol; 2000 Apr; 56(1):69-74. PubMed ID: 10853881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis alters tolbutamide pharmacokinetics in rats with experimental acute renal failure.
    Aiba T; Horiuchi M; Makita T; Komori Y; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):291-6. PubMed ID: 16946556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pharmacokinetic interaction between ticagrelor and tolbutamide, a cytochrome P450 2C9 substrate, in healthy volunteers.
    Teng R; Mitchell P; Butler K
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):305-12. PubMed ID: 23380426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats.
    Nishimura N; Naora K; Hirano H; Iwamoto K
    J Pharm Pharmacol; 1998 Feb; 50(2):231-6. PubMed ID: 9530993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady state pharmacokinetics and dose equivalents of oral clodronate in renal failure.
    Mäkelä S; Saha H; Ala-Houhala I; Liukko-Sipi S; Ylitalo P
    Int J Clin Pharmacol Ther; 2011 Feb; 49(2):128-36. PubMed ID: 21255529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral activated charcoal on the systemic clearance of gentamicin in rabbits with acute renal failure.
    Hasan MM; el-Sayed YM; Abdelaziz AA
    J Pharm Pharmacol; 1990 Feb; 42(2):85-8. PubMed ID: 1972407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of tolbutamide-containing tablet preparations.
    Barthel W; Böhm C; Hüller G; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):43-6. PubMed ID: 9021442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sho-saiko-to (xiao chai hu tang), a Chinese traditional medicine, on the gastric function and absorption of tolbutamide in rats.
    Nishimura N; Naora K; Hirano H; Iwamoto K
    Yakugaku Zasshi; 2001 Feb; 121(2):153-9. PubMed ID: 11218729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.
    Stangier J; Rathgen K; Stähle H; Mazur D
    Clin Pharmacokinet; 2010 Apr; 49(4):259-68. PubMed ID: 20214409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.